Patient Guide: Evaluation of Direct Antiviral Treatments Against SARS-CoV-2 in Immunocompromised Patients With Covid-19. A G2i Study, National Multicenter Observational and Retrospective From June 2023 to April 2024

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 16 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT06683937
Status: NOT_YET_RECRUITING
Condition: Immunocompromised Patients, SARS-CoV-2 Disease
Phase: Not Specified

Find a Study Location Near You

This study is available at 16 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Angers,
  • Caen,
  • Colmar,
  • • And 13 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily